OSRHW Company Profile and Key Details

Average 10-day trading volume of 27.13 thousand shares is below the 3-month average of 61.95 thousand, indicating normal recent market interest.

OSR Holdings, Inc. earnings surprise history is a mixed track record. The quarter that ended May 13, 2026, missed forecasts by -68.97%.

Our AI price prediction model suggests that OSR Holdings, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows OSR Holdings, Inc. trading at a premium to the broader market with a P/E of -0.14.

OSR Holdings, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.34. This means the shares are trading below this model’s fair value.

The stock is currently within 5% of its 52-week high $0.04 and $0.06. With a market capitalization of about $1.47 million, OSR Holdings, Inc. is classified as a micro-cap and shows market-like volatility (beta ~0.86). Key stats such as the average daily volume over the past year has been around 33.11 thousand shares, volume is running light vs its 52-week average. Headquartered in Bellevue, WA, OSR Holdings, Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Kuk Hyoun Hwang, the company employs approximately 19 people and listed since March 21, 2023. OSR Holdings, Inc. operates as a blank check company.

OSR Holdings, Inc. trades at a P/E ratio of -0.14, slightly below the S&P 500 average, with a price-to-sales ratio of 4.08 and a price-to-book ratio of 0.02 suggesting the stock is closer to book value. The P/FCF stands at -1.97, also above market averages.